Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome

BACKGROUND: The clustering of cardiovascular risk factors is termed the metabolic syndrome (MS), which strongly predicts the risk of diabetes and cardiovascular disease (CVD). Adipokines may contribute to the development of obesity and insulin resistance and may be a causal link between MS, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, M. K., Dutta, M. K., Mahalle, Namita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263179/
https://www.ncbi.nlm.nih.gov/pubmed/22276262
http://dx.doi.org/10.4103/2230-8210.91206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263179/
https://www.ncbi.nlm.nih.gov/pubmed/22276262
http://dx.doi.org/10.4103/2230-8210.91206

Ejemplares similares